PUMA BIOTECHNOLOGY, INC.·4/A

Feb 23, 4:24 PM ET

Ludwig Jeffrey Jerome 4/A

4/A · PUMA BIOTECHNOLOGY, INC. · Filed Feb 23, 2021

Insider Transaction Report

Form 4/AAmended
Period: 2021-02-17
Ludwig Jeffrey Jerome
Chief Commercial Officer
Transactions
  • Award

    COMMON STOCK

    2021-02-17+36,06936,069 total
Footnotes (1)
  • [F1]Subject to the Grantee's continued service with the Company through the applicable vesting date, the Restricted Stock Units shall vest with respect to (i) one-third (1/3) of the Restricted Stock Units on the first anniversary of the vesting commencement date of January 1, 2021 (the "Vesting Commencement Date") and (ii) one-sixth (1/6th) of the Restricted Stock Units on each of July 1, 2022, January 1, 2023, July 1, 2023 and January 1, 2024.

Documents

1 file
  • 4
    doc4a.xml

    FORM 4/A SUBMISSION